Research

Cellular

MASLD presents extrahepatic manifestations such as cardiovascular disease, type 2 diabetes, and chronic kidney disease.

Clinicians should consider the broader health implications of MASLD beyond liver health.

StrongSupportsmedium confidence
MASLD extends beyond the liver, presenting extrahepatic manifestations such as cardiovascular disease, type 2 diabetes, endocrine disorders such as hypothyroidism and polycystic ovarian syndrome, chronic kidney disease, psoriasis, and extrahepatic malignancies.
Anoushka Shenoy et al. · Metabolism and Target Organ Damage · 2025

Why this rating

The claim is based on a review of current evidence.

Source

Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease

Anoushka Shenoy et al. · Metabolism and Target Organ Damage · 2025

DOI 10.20517/mtod.2025.73

reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →